Company research
Biotech Acquisition Co
CIK 1825413Updated Oct 6, 2026
Securities
Name history
Biotech Acquisition Company · through Sep 21, 2020
BIOT price & chart
Historical security
This listing closed Feb 2, 2023. Live provider charts are shown only for current listings.
In the news
Instinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth ↗
Recent filings
Show 5 more recent filings
Financials
FY 2021 · USDSource
Source
balance sheet · annual statements
| Line item | Q3 2022 | Q3 2021 | Q3 2020 | Q2 2022 | Q2 2021 | Q1 2022 | Q1 2021 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| AssetsUSD | 231,389,235Source | 230,689,599Source | 89,500Source | 230,424,110Source | 231,286,422Source | 230,351,067Source | 231,504,250Source | 230,320,701Source | 89,500Source |
| Current assets: | |||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 13,145Source | 402,397Source | — | 1,696Source | 936,270Source | 104,056Source | 676,564Source | 91,407Source | — |
| Assets, CurrentUSD | 95,252Source | 674,159Source | — | 145,383Source | 1,276,780Source | 309,323Source | 1,500,343Source | 299,463Source | — |
| LIABILITIES AND EQUITY | |||||||||
| LiabilitiesUSD | 13,215,210Source | 20,552,553Source | 69,500Source | 13,511,545Source | 24,091,346Source | 22,822,396Source | 19,241,650Source | 27,469,212Source | — |
| Stockholders’ equity: | |||||||||
| Common Stock, Value, IssuedUSD | 575Source | 575Source | — | 575Source | 278Source | 575Source | 227Source | 575Source | — |
| Additional Paid in CapitalUSD | — | — | 24,425Source | — | 7,525,141Source | — | 2,457,671Source | — | 24,425Source |
| Retained Earnings (Accumulated Deficit)USD | -13,120,533Source | -19,878,969Source | -5,000Source | -13,366,737Source | -2,525,994Source | -22,471,904Source | 2,541,530Source | -27,170,324Source | -5,000Source |
| Stockholders' Equity Attributable to ParentUSD | -13,119,958Source | -19,878,394Source | 20,000Source | -13,366,162Source | -22,814,566Source | -22,471,329Source | -17,741,307Source | -27,169,749Source | 20,000Source |
| Liabilities and EquityUSD | 231,389,235Source | 230,689,599Source | 89,500Source | 230,424,110Source | 231,286,422Source | 230,351,067Source | 231,504,250Source | 230,320,701Source | 89,500Source |
| Current liabilities: | |||||||||
| Liabilities, CurrentUSD | 3,517,792Source | 358,553Source | — | 3,321,376Source | 331,346Source | 2,220,780Source | 91,650Source | 313,812Source | 69,500Source |
cash flow · annual statements
| Line item | Q4 2021 | Q3 2022 | Q3 2021 | Q2 2022 | Q2 2021 | Q1 2022 | Q1 2021 | FY 2021 |
|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | 2,941,970Source | — | -5,067,524Source | 4,677,182Source | 2,546,530Source | -6,864,581Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | -102,331Source | -864,719Source | -1,465,214Source |
| Cash flows from investing activities: | ||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -230,000,000Source | -230,000,000Source |
| Cash flows from financing activities: | ||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | 114,980Source | 231,541,283Source | 231,556,621Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | 13,145Source | 402,397Source | 1,696Source | 936,270Source | 104,056Source | 676,564Source | 91,407Source |
| Additional Financial Items | ||||||||
| Investment Income, InterestUSD | — | — | — | — | — | 20,506Source | 3,907Source | 21,238Source |
| Net Income (Loss) Attributable to ParentUSD | — | 1,261,460Source | 2,941,970Source | 9,383,894Source | -5,067,524Source | 4,677,182Source | 2,546,530Source | -6,864,581Source |
| Operating Costs and ExpensesUSD | — | 246,572Source | 629,850Source | 1,264,536Source | 463,281Source | 1,897,111Source | 147,072Source | 1,570,165Source |
| Payments of Financing CostsUSD | — | — | — | — | — | — | 364,217Source | 374,749Source |
| Stock or Unit Option Plan ExpenseUSD | — | — | — | — | — | — | 520,319Source | 520,319Source |
income statement · annual statements
| Line item | Q4 2021 | Q3 2022 | Q3 2021 | Q2 2022 | Q2 2021 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|
| Operating Income (Loss) | — | —Source | —Source | —Source | —Source | —Source | —Source |
| Net Income (Loss) Attributable to Parent | — | —Source | —Source | —Source | —Source | —Source | —Source |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | —Source | — | —Source |
| Investment Income, Interest | — | — | — | — | — | —Source | —Source |
| Management Fee Expense | — | — | —Source | — | —Source | — | — |
| Operating Costs and Expenses | — | —Source | —Source | —Source | —Source | —Source | —Source |